LA Times: Supreme Court spurns challenge to stem cell research
By David G. Savage
The Los Angeles Times
January 7, 2013
WASHINGTON -- The Supreme Court has turned away a challenge to President Obama’s policy of expanding government-funded research using embryonic stem cells that scientists say may offer hope for new treatments for spinal injuries and Parkinson’s disease.
The court’s action brings a quiet end to a lawsuit that briefly threatened to derail all funding for such research.
A federal judge in Washington in 2010 ordered the National Institutes of Health to halt funding of the research, citing a long-standing congressional ban on spending for research in which “human embryos are destroyed.”
But an appeals court overturned that order and ruled last year that the ban applied only to research which destroyed human embryos so as to obtain stem cells.
President George W. Bush in 2001 had allowed limited research on several stem cell lines that were already in existence. Upon taking office in 2009, President Obama went further and said NIH could conduct “scientifically worthy human stem cell research to the extent permitted by law.” Under guidelines issued by NIH, researchers can used stem line cells derived from donated frozen embryos that are no longer needed for fertility treatments.
The three-judge panel that upheld the Obama administration’s guidelines was made up Chief Judge David Sentelle, a Reagan appointee; Judge Karen Henderson, appointed by President George H.W. Bush; and Judge Janice Rogers Brown, an appointee of President George W. Bush.
Two researchers who work with adult stem lines, including Dr. James Sherley of the Boston Biomedical Research Institute, brought the lawsuit. They were represented by several groups, including the Law of Life Project. Samuel Casey, the group’s general counsel, called the human stem cell research “an ethical tragedy as well as a waste of the taxpayer’s money.”
They appealed to the high court in the fall, but the justices denied the appeal without comment or dissent in the case, Sherley v. Sebelius.
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Call for applications
Taubman Institute to offer six new scholar grants
The institute is accepting applications through Dec. 1 for its flagshop Taubman Scholar grant program, which is open to clinician-scientists on the U-M Medical School Faculty. Grants are $150,000 per year for three years.
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
Is there a link between tonsils and psoriasis?
Trial tested the effect of tonsillectomy on the skin disease
Taubman Emerging Scholar Dr. Johann Gudjonsson and colleagues found that people who had their tonsils removed showed improvment.
Click here to read the entire story
Fall Visiting Professor Lectures schedule
Distinguished guest speakers include experts in lung, muscle and nerve diseases
Click here for the lineup
Breast cancer clinical trial enrolling patients
Research by Taubman Scholar Dr. Max Wicha into breast cancer stem cells is the basis for a new human clinical trial of the drug Reparixin, which scientists hope will curb the growth of the tumor-fueling cells.